Author:
Benoit L.,Bentivegna E.,Koual M.,Nguyen-Xuan H.-T.,Mereaux J.,Azaïs H.,Bats A.-S.
Reference42 articles.
1. Centre experts tumeur malignes rares gynécologiques. https://www.ovaire-rare.org/Default.aspx.
2. Non-epithelial ovarian cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up;Ray-Coquard;Ann Oncol,2018
3. Oncology (ESGO) TES of G. ESGO 2017 congress, November 4–7, 2017 in Vienna, Austria. ESGO gynae-oncology guidelines. https://guidelines.esgo.org/cervical-cancer/guidelines/recommendations/.
4. FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication;Prat;J Gynecol Oncol,2015
5. Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumours: guidelines from the French national network dedicated to rare gynaecological cancers;Rousset-Jablonski;Eur J Cancer,2019